Masataka Sata
Professor
Faculty of Medicine
University of Tokushima
Japan
Biography
Masataka Sata has done his PhD From University of Tokyo in 1999. Currently he is working as Professor in Faculty of Medicine in Tokushima University. His research interests are Cardiovascular Medicine. Several papers of his work were published in reputed international journals. He is the member of The Japanese Society of Internal Medicine, The Japanese Circulation Society, The Japanese College of Cardiology, The Society of Cardiovascular Endocrinology and Metabolism, American Heart Association, International Society for Heart Research, American Association for the Advancement of Science, Japanese Heart Rhythm Society.
Research Interest
Cardiovascular Medicine. Research on arteriosclerosis, regenerative medicine, medication therapy, lifestyle-related diseases.
Publications
-
M Asakura, J Kim, H Asanuma, T Hamasaki, K Tsukahara, Y Higashino, T Ishikawa, Y Nakama, S Koba, Y Maruyama, M Tsujimoto, H Himeno, T Ohkusa, J Fujino, M Shimizu, T Endo, S Yoda, T Muroya, T Murohara, N Ohte, H Suzuki, T Kohno, K Fukui, T Shiono, H Takase, H Uzui, Y Nagai, Y Hshimoto, S Ikeda, S Mizuno, K Tamita, M Fujita, K Satake, Y Kinoshita, T Nunohori, S Sakagami, J Higaki, I Morii, R Swada, Y Hiasa, T Shigemasa, M Nakahama, Masataka Sata, O Doi, T Ueda, T Yamada, T Yamanouchi, H Yamaguchi, Y Morita, H Hayashi and M Kitakaze. Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction? Cardiovascular Drugs and Therapy. 2017.
-
Kenya Kusunose, Hirotsugu Yamada, S Nisino, A Isii, Y Hirata, H Seno, Y Saijo, Takayuki Ise, Koji Yamaguchi, Shusuke Yagi, Takeshi Soeki, Tetsuzo Wakatsuki and Masataka Sata. RV Myocardial Strain During Pre-Load Augmentation Is Associated With Exercise Capacity in Patients With Chronic HF. JACC. Cardiovascular Imaging. 2017, 10(10): 1240-1249.
-
Michio Shimabukuro, A Tanaka, Masataka Sata, K Dai, Y Sibata, Y Inoue, H Ikenaga, S Kishimoto, K Ogasawara, A Takshima, T Niki, O Arasaki, K Oshiro, Y Mori, M Ishihara and K Nobe. Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study. Cardiovasc Diabetol. 2017, 16(19): 86.
